行业观察

ElsevierApr 8 2026 A recent study in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined the impact of a Food is Medicine (FIM) and food literacy education program

UMass Chan Medical SchoolApr 8 2026 A Phase I clinical trial of a human monoclonal antibody discovered and developed at UMass Chan Medical School for the prevention of Lyme disease in the U.S. was wel

Universitat Autònoma de Barcelona (UAB)Apr 8 2026 A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials,

University of Alabama at BirminghamApr 8 2026 Alzheimer's disease is a progressive neurodegenerative disorder that slowly impairs memory, affects thinking skills, and eventually interferes with daily

InSilico MedicineApr 8 2026 The NR3C1 (nuclear receptor subfamily 3 group C member 1) gene encodes the glucocorticoid receptor (GR), a nuclear receptor vital for maintaining physiological homeostasis,

University of TorontoApr 8 2026 Older Canadians who are socially connected, physically healthy, and spiritually engaged are significantly more likely to experience complete mental health, according to

4月7日，美国临床试验收录网站显示，Nurix Therapeutics启动了Bexobrutideg（NX-5948）的首个III期临床试验。该研究是一项随机、多中心、开放标签III期临床试验（n=620），旨在评估Bexobrutideg（口服，每日1次）对比Pirtobrutinib（口服，每日1次）治疗既往接受过共价BTK抑制剂治疗的复发或难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（CLL

2026年3月9日，海糖（南通）生物医药科技有限公司自主研发的化学1类新药AOSC已正式获得国家药品监督管理局（NMPA）批准，进入临床研究（受理号：CXHL2501496）。AOSC为治疗急性肾损伤（AKI）进入临床阶段的全球首个海洋寡糖新药。Liang B, et al, Alginate oligosaccharide prevents renal ischemia-reperfusion

2026年4月7日，Halozyme Therapeutics宣布其全资子公司Halozyme Hypercon与Vertex Pharmaceuticals达成一项全球独家合作与许可协议。根据协议，Vertex获得Halozyme的Hypercon™技术授权，可用于最多三个药物靶点。Hypercon是一种创新的微粒技术，能够实现药物和生物制剂的高度浓缩，从而在相同剂量下减少注射体积，支持便捷的居

随着抗体药物偶联物（ADC）不断向双特异性、双载药等更为复杂的结构方向演进，其关键质量属性（CQA）的精准表征面临着日益严峻的挑战。本次报告将聚焦于构建稳健高效的分析策略，针对性破解上述技术难题。报告核心内容涵盖新型 ADC 制剂的药物抗体比（DAR）测定、载药分布表征、游离药物分析以及电荷异质性分析等关键技术方向。助力听众更深入了解如何搭建适配型分析技术平台、突破方法开发过程中的共性瓶颈，同时保

XPANCEO Research on Natural Science LLCApr 8 2026 XPANCEO, a deep-tech company developing smart contact lens, has unveiled a passive eye-tracking system that achieves industry-level measurement precis

American Gastroenterological AssociationApr 8 2026 For people living with celiac disease, the fear of gluten exposure can extend beyond food - sometimes even into moments of intimacy. A new study offe

WileyApr 8 2026 Higher optimism is associated with a lower risk of developing dementia, according to a new study in the Journal of the American Geriatrics Society. In the analysis of data from the Hea

By Dr. Liji Thomas, MDReviewed by Lauren HardakerApr 8 2026 A new international study reveals that while ChatGPT may deliver clearer, more engaging answers on PCOS than traditional resources, its role

Chiba UniversityApr 8 2026 Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases such as cancer by binding to s